"Iopamidol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiological procedures.
| Descriptor ID |
D007479
|
| MeSH Number(s) |
D02.241.223.100.400.880.410 D02.455.426.559.389.127.375.880.410
|
| Concept/Terms |
B-15,000- B-15,000
- B 15,000
- B15,000
- B-15000
- B 15000
- B15000
|
Below are MeSH descriptors whose meaning is more general than "Iopamidol".
Below are MeSH descriptors whose meaning is more specific than "Iopamidol".
This graph shows the total number of publications written about "Iopamidol" by people in this website by year, and whether "Iopamidol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Iopamidol" by people in Profiles.
-
Jogo A, Yamamoto A, Kaminoh T, Nakano M, Kageyama K, Sohgawa E, Hamamoto S, Sakai Y, Hamuro M, Nishida N, Miki Y. Utility of low-dose gelatin sponge particles and 5% ethanolamine oleate iopamidol mixture in retrograde transvenous obliteration (GERTO) for gastric varices. Br J Radiol. 2020 Apr; 93(1108):20190751.
-
Yamamoto A, Jogo A, Kageyama K, Sohgawa E, Hamamoto S, Hamuro M, Kamino T, Miki Y. Utility of Coil-Assisted Retrograde Transvenous Obliteration II (CARTO-II) for the Treatment of Gastric Varices. Cardiovasc Intervent Radiol. 2020 Apr; 43(4):565-571.
-
Sundaram B, Kuriakose JW, Stojanovska J, Watcharotone K, Parker RA, Kazerooni EA. Thoracic central venous evaluation: comparison of first-pass direct versus delayed-phase indirect multidetector CT venography. Clin Imaging. 2015 May-Jun; 39(3):412-6.